2,257
Views
5
CrossRef citations to date
0
Altmetric
Reviews

FLASH ultra-high dose rates in radiotherapy: preclinical and radiobiological evidence

, , , , &
Pages 127-135 | Received 29 Mar 2021, Accepted 01 Nov 2021, Published online: 16 Dec 2021

References

  • Adrian G, Konradsson E, Lempart M, Bäck S, Ceberg C, Petersson K. 2019. The FLASH effect depends on oxygen concentration. Br J Radiol. 11:2019070.
  • Allen BD, Acharya MM, Montay-Gruel P, Jorge PG, Bailat C, Petit B, Vozenin MC, Limoli C. 2020. Maintenance of tight junction integrity in the absence of vascular dilation in the brain of mice exposed to ultra-high-dose-rate FLASH irradiation. Radiat Res. 194(6):625–635.
  • Andreassi MG, Borghini A, Pulignani S, Baffigi F, Fulgentini L, Koester P, Cresci M, Vecoli C, Lamia D, Russo G, et al. 2016. Radiobiological effectiveness of ultrashort Laser-Driven Electron Bunches: micronucleus frequency, telomere shortening and cell viability . Radiat Res. 186(3):245–253.
  • Babayan N, Hovhannisyan G, Grigoryan B, Grigoryan R, Sarkisyan N, Tsakanova G, Haroutiunian S, Aroutiounian R. 2017. Dose-rate effect of ultrashort electron beam radiation on DNA damage and repair in vitro. J Radiat Res. 58(6):894–897.
  • Bazalova-Carter M, Qu B, Palma B, Hårdemark B, Hynning E, Jensen C, Maxim PG, Loo BW. 2015. Treatment planning for radiotherapy with very high-energy electron beams and comparison of VHEE and VMAT plans. Med Phys. 42(5):2615–2625.
  • Beddok A, Fouillade C, Quelennec E, Favaudon V. 2017. In vitro study of FLASH vs. conventional dose rate irradiation: cell viability and DNA damage repair. Estro. 123:S9–S10.
  • Bourhis J, Montay-Gruel P, Gonçalves Jorge P, Bailat C, Petit B, Ollivier J, Jeanneret-Sozzi W, Ozsahin M, Bochud F, Moeckli R, et al. 2019. Clinical translation of FLASH radiotherapy: why and how? Radiother Oncol. 139:11–17.
  • Bourhis J, Sozzi WJ, Jorge PG, Gaide O, Bailat C, Duclos F, Patin D, Ozsahin M, Bochud F, Germond JF, et al. 2019. Treatment of a first patient with FLASH-radiotherapy. Radiother Oncol. 139:18–22.
  • Brahme A, Nilsson J, Belkic D. 2001. Biologically optimized radiation therapy. Acta Oncol. 40(6):725–734.
  • Buonanno M, Grilj V, Brenner DJ. 2019. Biological effects in normal cells exposed to FLASH dose rate protons. Radiother Oncol. 139:51–55.
  • Chabi S, Van TH, Leavitt R, Poglio S, Jorge PG, Jaccard M, Petersson K, Petit B, Roméo PH, Pflumio F, et al. 2020. Ultra-high dose rate FLASH and conventional dose rate irradiation differentially affect human acute lymphoblastic leukemia and normal hematopoiesis. Int J Radiat Oncol Biol Phys. 109(3):819–829.
  • Dale RG. 1985. The Application of the Linear-Quadratic Dose-Effect Equation to Fractionated and Protracted Radiotherapy. Br J Radiol. 58(690):515–528.
  • DesRosiers C, Moskvin V, Bielajew AF, Papiez L. 2000. 150-250 meV electron beams in radiation therapy. Phys Med Biol. 45(7):1781–1805.
  • Durante M, Brauer-Krisch E, Hill M. 2018. Faster and safer? FLASH ultra-high dose rate in radiotherapy. Br J Radiol. 91(1082):20170628.
  • Favaudon V, Caplier L, Monceau V, Pouzoulet F, Sayarath M, Fouillade C, Poupon M-F, Brito I, Hupe P, Bourhis J. 2014. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci Transl Med. 6:24593.
  • Fouillade C, Curras-Alonso S, Giuranno L, Quelennec E, Heinrich S, Bonnet-Boissinot S, Beddok A, Leboucher S, Karakurt HU, Bohec M, et al. 2020. FLASH irradiation spares lung progenitor cells and limits the incidence of radio-induced senescence. Clin Cancer Res. 26(6):1497–1506.
  • Fourkal E, Velchev I, Ma CM, Fan J. 2011. Linear energy transfer of proton clusters. Phys Med Biol. 56(10):3123–3136.
  • Garau MM. 2017. Radiobiology of Stereotactic Body Radiation Therapy (SBRT). Rep Prac Oncol Radiother. 22:86–95.
  • Hall EJ, Brenner DJ. 1991. The dose-rate effect revisited: radiobiological considerations of importance in radiotherapy. Int J Radiat Oncol Biol Phys. 21(6):1403–1414.
  • Hall EJ, Giaccia AJ. 2012. Radiobiology for radiologist. Baltimore: Lippincott Williams & Wilkins.
  • Hendry JH, Moore JV, Hodgson BW, Keene JP. 1982. The constant low oxygen concentration in all the target cells for mouse tail radionecrosis. Radiat Res. 92(1):172–181.
  • Hornsey S, Alper T. 1966. Unexpected dose-rate effect in the killing of mice by radiation . Nature. 210(5032):212–213.
  • Hornsey S, Bewley DK. 1971. Hypoxia in mouse intestine induced by electron irradiation at high dose-rates. Int J Radiat Biol Relat Stud Phys Chem Med. 19(5):479–483.
  • King CR. 2002. LDR vs. HDR Brachytherapy for Localized Prostate Cancer: The View from Radiobiological Models. Brachytherapy. 1(4):219–226.
  • Labate L, Palla D, Panetta D, Avella F, Baffigi F, Brandi F, Di Martino F, Fulgentini L, Giulietti A, Köster P, et al. 2020. Toward an effective use of laser-driven very high energy electrons for radiotherapy: Feasibility assessment of multi-field and intensity modulation irradiation schemes. Sci Rep. 10(1):17307.
  • Lea DE. 1938. A Theory of the Action of Radiations on Biological Materials Capable of Recovery Part 1. BJR. 11(127):489–497.
  • Lempart M, Blad B, Adrian G, Bäck S, Knöös T, Ceberg C, Petersson K. 2019. Modifying a clinical linear accelerator for delivery of ultra-high dose rate irradiation. Radiother Oncol. 139:40–45.
  • Lomax ME, Folkes LK, O'Neill P. 2013. Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol. 25(10):578–585.
  • Matsuya Y, McMahon SJ, Tsutsumi K, Sasaki K, Okuyama G, Yoshii Y, Mori R, Oikawa J, Prise KM, Date H. 2018. Investigation of dose-rate effects and cell-cycle distribution under protracted exposure to ionizing radiation for various dose-rates. Sci Rep. 8(1):14.
  • Maxim PG, Tantawi SG, Loo BW. Jr. 2019. PHASER: a platform for clinical translation of FLASH cancer radiotherapy. Radiother Oncol. 139:28–33.
  • Montay-Gruel P, Acharya MM, Gonçalves Jorge P, Petit B, Petridis IG, Fuchs P, Leavitt R, Petersson K, Gondré M, Ollivier J, et al. 2021. Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice. Clin Cancer Res. 27(3):775–784.
  • Montay-Gruel P, Acharya MM, Petersson K, Alikhani L, Yakkala C, Allen BD, Ollivier J, Petit B, Jorge PG, Syage AR, et al. 2019. Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species. Proc Natl Acad Sci USA. 116(22):10943–10951.
  • Montay-Gruel P, Bouchet A, Jaccard M, Patin D, Serduc R, Aim W, Petersson K, Petit B, Bailat C, Bourhis J, et al. 2018. X-rays can trigger the FLASH effect: ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice. Radiother Oncol. 129(3):582–588.
  • Montay-Gruel P, Petersson K, Jaccard M, Boivin G, Germond J-F, Petit B, Doenlen R, Favaudon V, Bochud F, Bailat C, et al. 2017. Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s. Radiother Oncol. 124(3):365–369.
  • O’Connor MJ. 2015. Targeting the DNA damage response in cancer. Mol Cell. 60(4):547–560.
  • Orton CG. 2001. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys. 49(1):183–189.
  • Phillips MH, Griffin TW. 1999. Physics of high-linear energy transfer (LET) particles and protons. In: Perez CA, and Brady LW, editors. Principles and practice of radiation oncology. Philadelphia (PA): Lippincott-Raven Publishers.
  • Pratx G, Kapp DS. 2019. Ultra-High-Dose-Rate FLASH Irradiation May Spare Hypoxic Stem Cell Niches in Normal Tissues. Int J Radiat Oncol Biol Phys. 105(1):190–192.
  • Schüler E, Trovati S, King G, Lartey F, Rafat M, Villegas M, Praxel AJ, Loo BW, Maxim PG. 2017. Experimental platform for ultra-high dose rate flash irradiation of small animals using a clinical linear accelerator. Inter J Rad Oncol Biol Phys. 97(1):195–203.
  • Sistrunk E, Alessi DA, Bayramian A, Chesnut K, Erlandson A, Galvin TC, Gibson D, Nguyen H, Reagan B, Schaffers K, et al. 2019. Laser technology development for high peak power lasers achieving kilowatt average power and beyond. In: Proceedings of the SPIE. Prague: Czech Republic; p. 8.
  • Spear FG, Grimmett LG. 1933. The biological response to gamma rays of radium as a function of the intensity of radiation. BJR. 6(67):387–403.
  • Spitz DR, Buettner GR, Petronek MS, St-Aubin JJ, Flynn RT, Waldron TJ, Limoli CL. 2019. An integrated physico-chemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses. Radiother Oncol. 139:23–27.
  • Taba ST, Gureyev TE, Alakhras M, Lewis S, Lockie D, Brennan PC. 2018. X-ray phase-contrast technology in breast imaging: principles, options, and clinical application. AJR Am J Roentgenol. 211(1):133–145.
  • Town CD. 1967. Radiobiology. Effect of high dose rates on survival of mammalian cells. Nature. 215(5103):847–848.
  • UNSCEAR 2001. Report of the United States Nations Scientific Committee on the Effects of Atomic Radiation to the General Assembly. Annex G: Biological effects at low radiation doses. United Nations, New York, USA
  • van Leeuwen CM, Oei AL, Crezee J, Bel A, Franken NAP, Stalpers LJA, Kok HP. 2018. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies. Radiat Oncol. 13(1):96.
  • van Marlen P, Dahele M, Folkerts M, Abel E, Slotman BJ, Verbakel WFAR. 2020. Bringing FLASH to the clinic: treatment planning considerations for ultrahigh dose-rate proton beams. Int J Radiat Oncol Biol Phys. 106(3):621–629.
  • Vozenin M-C, De Fornel P, Petersson K, Favaudon V, Jaccard M, Germond J-F, Petit B, Burki M, Ferrand G, Patin D, et al. 2019. The advantage of Flash radiotherapy confirmed in mini-pig and cat-cancer patients. Clin Cancer Res. 25(1):35–42.
  • Vozenin M-C, Hendry JH, Limoli CL. 2019. Biological benefits of ultra-high dose rate flash radiotherapy: sleeping beauty awoken. Clin Oncol. 31(7):407–415.
  • Ward JF. 1988. DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Prog Nucleic Acid Res Mol Biol. 35:95–125.
  • Wilson JD, Hammond EM, Higgins GS, Petersson K. 2020. Ultra-High Dose Rate (FLASH) radiotherapy: silver bullet or fool’s gold? Front Oncol. 9:1–12.
  • Wilson P, Jones B, Yokoi T, Hill M, Vojnovic B. 2012. Revisiting the ultra-high dose rate effect: implications for charged particle radiotherapy using protons and light ions. Br J Radiol. 85(1018):e933–e939.
  • Zhou G. 2020. Mechanisms underlying FLASH radiotherapy, a novel way to enlarge the differential responses to ionizing radiation between normal and tumor tissues. Radiat Med Protect. 1(1):35–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.